SCHEMBL10502310

SCHEMBL10502310

COc1cc(OC)cc(-n2[se]c3ccccc3c2=S)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 6/20 0.52
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ QSOX1 O00391 1/20 0.39
▸ RGS12 O14924 1/20 0.39
▸ PMM2 O15305 1/20 0.39
▸ PLIN1 O60240 1/20 0.39
▸ GMNN O75496 1/20 0.39
▸ BBOX1 O75936 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYBB P04839 1/20 0.39
▸ BCHE P06276 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501336 0.88 METAP2 (0.50) METAP2MEN1KMT2AKDM4EQSOX1
SCHEMBL10502111 0.88 METAP2 (0.68) METAP2MEN1KMT2AATMKDM4E
SCHEMBL10501284 0.81 METAP2 (0.78) METAP2MEN1KMT2AKDM4EQSOX1
SCHEMBL10502572 0.81 METAP2 (0.47) METAP2MEN1KMT2AKDM4EQSOX1
SCHEMBL10501995 0.81 METAP2 (0.47) METAP2
SCHEMBL10501830 0.80 METAP2 (0.48) METAP2MEN1KMT2AATMKDM4E
SCHEMBL10503543 0.79 METAP2 (0.50) METAP2MEN1KMT2AATMKDM4E
SCHEMBL10500974 0.79 METAP2 (0.54) METAP2KMT2AKDM4EALDH1A1LMNA
SCHEMBL10501743 0.79 METAP2 (0.54) METAP2KMT2AKDM4EALDH1A1LMNA
SCHEMBL10501589 0.78 METAP2 (0.61) METAP2MEN1KMT2AKDM4EQSOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback